Neuroprotective potential of Afzelin: A novel approach for alleviating catalepsy and modulating Bcl-2 expression in Parkinson's disease therapy

• Egile Nagusiak: Khalid M. Alharthy (Egilea), Summya Rashid (Egilea), Hasan S. Yusufoglu (Egilea), Saleh I. Alqasoumi (Egilea), Majid Ahmad Ganaie (Egilea), Aftab Alam (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2024-02-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

The lost dopaminergic neurons in the brain prevent mobility in Parkinson's disease (PD). It is impossible to stop the disease's progress by means of symptoms management. Research focuses on oxidative stress, mitochondrial dysfunction, and neuronal degeneration. Exploration of potential neu...